Manufacturers pay $6.5 billion to healthcare providers in 2014

The government released new data showing how much pharma and device companies spent for research and marketing purposes last year.

Five things for pharma marketers to know: Tuesday, June 30

Vertex's cystic-fibrosis drug approval likely to come this week; Roche's multiple-sclerosis treatment hits primary and secondary endpoints; Regeneron/Sanofi debut film about high cholesterol

Patient Engagement: All Grown Up—Patient Engagement Comes of Age

Patient engagement has evolved from something nice to do to an essential part of the pharma marketer's toolbox. Sarah ­Mahoney ­reviews the important ­milestones in ...

Patients in Clinical Trials: Fifty Shades of Hay

Hunting for qualified clinical research subjects can be like finding the proverbial needle in the haystack. Until, that is, you find where the needled haystacks ...

Latest

Top 100 Agencies 2015: Guidemark Health

Top 100 Agencies 2015: Guidemark Health

Unifying legacy business with winning business

Top 100 Agencies 2015: GSW

Top 100 Agencies 2015: GSW

Being the voice of the patient drives the creative teams at this Ohio agency

Top 100 Agencies 2015: Greater Than One

Top 100 Agencies 2015: Greater Than One

The wave of the future for AOR

Top 100 Agencies 2015: Giant

Top 100 Agencies 2015: Giant

Expansion to the East Coast propelled this San Francisco stalwart

Top 100 Agencies 2015: GHG Summit

Top 100 Agencies 2015: GHG Summit

Internal challenges fueled innovation across the board for this New Jersey firm

Top 100 Agencies 2015: GHG

Top 100 Agencies 2015: GHG

An advertising beacon whose lights beam brighter every year

Top 100 Agencies 2015: GCG Healthcare

Top 100 Agencies 2015: GCG Healthcare

Bigger budgets from a recovering pharma industry spell internal growth for this Texas agency

Top 100 Agencies 2015: GA Communication Group

Top 100 Agencies 2015: GA Communication Group

Fast and steady wins the race

Top 100 Agencies 2015: Flashpoint Medica

Top 100 Agencies 2015: Flashpoint Medica

A ten-year-old firm proves its mettle

Top 100 Agencies 2015: Fingerpaint

Top 100 Agencies 2015: Fingerpaint

An unconventional business model results in a dozen account wins

Top 100 Agencies 2015: FCB Health

Top 100 Agencies 2015: FCB Health

A behemoth gets even bigger

Top 100 Agencies 2015: Excitant Healthcare Advertising

Top 100 Agencies 2015: Excitant Healthcare Advertising

Focusing on a balanced marketing mix

Top 100 Agencies 2015: Evoke Health

Top 100 Agencies 2015: Evoke Health

Digital singularity leads to expansion

Top 100 Agencies 2015: Eveo

Top 100 Agencies 2015: Eveo

Restructuring yields a full 360-degree view of the client experience

Top 100 Agencies 2015: Entrée Health

Top 100 Agencies 2015: Entrée Health

Seeing demand for payer expertise

Agency Spotlight


Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.